𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Integrin expression in cutaneous malignant melanoma: Association of the α3/β1 heterodimer with tumor progression

✍ Scribed by P. G. Natali; A. Bartolazzi; R. Cavaliere; A. Bigotti; M. R. Nicotra

Publisher
John Wiley and Sons
Year
1993
Tongue
French
Weight
985 KB
Volume
54
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transformation and tumor progression are
Transformation and tumor progression are frequently associated with expression of the α3/β1 heterodimer in solid tumors
✍ Armando Bartolazzi; Cristina Cerboni; Maria R. Nicotra; Marcella Mottolese; Aldo 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 536 KB

The ability of tumor cells to interact with the extracellular matrix (ECM) is functionally mediated by a variety of receptor molecules among which the integrins are a well-characterized family of mediators. In this study we have investigated irnmunohistochemically the in vivo expression of the a,/Pl

Tumor progression in human malignant mel
Tumor progression in human malignant melanoma is associated with changes in α6/β1 laminin receptor
✍ Pier Giorgio Natali; Maria Rita Nicotra; Renato Cavaliere; Diana Giannarelli; Al 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 656 KB

Cells of the melanocytic lineage have been shown to be capable of producing laminin and to lose this property during transformation. In the present study, we have evaluated im- munohistochemically whether these changes are paralleled by an altered expression of the a6@l laminin receptor. Results of

Loss of expression of the p16INK4/CDKN2
Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage
✍ Lauri Talve; Ilari Sauroja; Yrjö Collan; Kari Punnonen; Tauno Ekfors 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 155 KB 👁 2 views

The G 1 /S checkpoint of the cell cycle is regulated by p16, p53 and RB tumor suppressor genes. Loss of expression of the p16 INK4 tumor suppressor protein, the product of the CDKN2 gene, has been associated with a wide variety of human malignancies. Mutations, loss of heterozygosity and deletions o

Interindividual pharmacokinetics variabi
Interindividual pharmacokinetics variability of the α4β1 integrin antagonist, 4-[1-[3-Chloro-4-[N′-(2-methylphenyl)ureido]phenylacetyl]-(4S)-fluoro-(2S)-pyrrolidine-2-yl]methoxybenzoic acid (D01-4582), in beagles is associated with albumin genetic polymorphisms
✍ Takashi Ito; Masayuki Takahashi; Kenichi Sudo; Yuichi Sugiyama 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

The interindividual pharmacokinetic variability of the a 4 b 1 integrin antagonist -4582) was observed in beagles. The involvement of albumin genetic polymorphism in this variability was investigated. The albumin genotype was analyzed by sequencing the albumin gene from liver and blood samples. The